Handelsinvest Investeringsforvaltning’s AbbVie ABBV Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,985	Closed	-$644K	–	113
2018 Q4	$644K	Buy	6,985 +1,540	+28%	+$135K	0.16%	91
2018 Q3	$515K	Hold	5,445	–	–	0.11%	97
2018 Q2	$504K	Sell	5,445 -2,786	-34%	-$272K	0.11%	90
2018 Q1	$779K	Sell	8,231 -2,200	-21%	-$242K	0.17%	76
2017 Q4	$1.01M	Hold	10,431	–	–	0.22%	73
2017 Q3	$927K	Hold	10,431	–	–	0.22%	73
2017 Q2	$756K	Sell	10,431 -29,269	-74%	-$1.97M	0.19%	77
2017 Q1	$2.59M	Hold	39,700	–	–	0.74%	51
2016 Q4	$2.49M	Buy	39,700 +10,000	+34%	+$610K	0.87%	49
2016 Q3	$1.87M	Hold	29,700	–	–	0.68%	66
2016 Q2	$1.84M	Hold	29,700	–	–	0.7%	64
2016 Q1	$1.7M	Hold	29,700	–	–	0.57%	68
2015 Q4	$1.76M	Buy	+29,700	New	+$1.71M	0.62%	63

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's ABBV Position: Q1 2019 in Review

Handelsinvest Investeringsforvaltning sold out of AbbVie (ABBV) in Q1 2019, closing a stake of 6,985 shares — an estimated $644K sold.

Handelsinvest Investeringsforvaltning first reported a position in ABBV in Q4 2015 and held it in 13 quarters. The position peaked at $2.59M in Q1 2017. 2,034 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

Handelsinvest Investeringsforvaltning reported no remaining AbbVie position as of Q1 2019 after selling out during the quarter.
Handelsinvest Investeringsforvaltning sold 6,985 AbbVie shares in Q1 2019, an estimated $644K.
Handelsinvest Investeringsforvaltning first reported a position in AbbVie in Q4 2015 and held it in 13 quarters.
Handelsinvest Investeringsforvaltning's AbbVie position peaked at $2.59M in Q1 2017.
2,034 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q1 2019, filed 11 Apr 2019.